MC
CME icon

Moors & Cabot’s CME Group CME Stock Holding History

Moors & Cabot’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.75M Buy
26,055
+35
+0.1% +$9.68K 0.22% 92
2026
Q1 		$7.69M Sell
26,020
-715
-3% -$212K 0.33% 57
2025
Q4 		$7.3M Buy
26,735
+227
+0.9% +$61.7K 0.31% 63
2025
Q3 		$7.16M Sell
26,508
-86
-0.3% -$23.4K 0.31% 65
2025
Q2 		$7.33M Buy
26,594
+471
+2% +$128K 0.34% 63
2025
Q1 		$6.93M Sell
26,123
-1,366
-5% -$337K 0.35% 57
2024
Q4 		$6.38M Buy
27,489
+217
+0.8% +$49.9K 0.3% 66
2024
Q3 		$6.02M Sell
27,272
-4,180
-13% -$865K 0.3% 70
2024
Q2 		$6.18M Buy
31,452
+2,853
+10% +$589K 0.33% 62
2024
Q1 		$6.16M Buy
28,599
+267
+0.9% +$56.1K 0.33% 64
2023
Q4 		$5.97M Buy
28,332
+115
+0.4% +$24.5K 0.37% 58
2023
Q3 		$5.65M Buy
28,217
+258
+0.9% +$51.3K 0.38% 55
2023
Q2 		$5.18M Buy
27,959
+1,727
+7% +$319K 0.34% 65
2023
Q1 		$5.02M Sell
26,232
-33
-0.1% -$5.97K 0.35% 65
2022
Q4 		$4.42M Buy
26,265
+1,194
+5% +$207K 0.31% 77
2022
Q3 		$4.44M Buy
25,071
+774
+3% +$153K 0.34% 70
2022
Q2 		$4.97M Buy
24,297
+1,031
+4% +$219K 0.36% 63
2022
Q1 		$5.53M Buy
23,266
+893
+4% +$210K 0.34% 65
2021
Q4 		$5.11M Buy
22,373
+654
+3% +$144K 0.31% 71
2021
Q3 		$4.22M Buy
21,719
+3,444
+19% +$698K 0.27% 86
2021
Q2 		$3.89M Buy
18,275
+7,576
+71% +$1.6M 0.27% 84
2021
Q1 		$2.17M Buy
10,699
+1,087
+11% +$214K 0.17% 137
2020
Q4 		$1.75M Sell
9,612
-861
-8% -$146K 0.15% 150
2020
Q3 		$1.75M Buy
10,473
+8,600
+459% +$1.45M 0.17% 134
2020
Q2 		$304K Sell
1,873
-284
-13% -$50.9K 0.03% 443
2020
Q1 		$372K Buy
2,157
+36
+2% +$7.17K 0.05% 310
2019
Q4 		$426K Sell
2,121
-41
-2% -$8.41K 0.04% 382
2019
Q3 		$363K Buy
+2,162
New +$452K 0.04% 397

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Moors & Cabot's CME Position: Q2 2026 in Review

Moors & Cabot increased its CME Group (CME) stake by 0.13% in Q2 2026, buying an estimated $9.68K and bringing the position to 26,055 shares worth $5.75M. The position accounts for 0.22% of the portfolio, ranked #92.

Moors & Cabot first reported a position in CME in Q3 2019 and has held it in 28 quarters since. The position peaked at $7.69M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Moors & Cabot held 26,055 shares of CME Group worth $5.75M as of Q2 2026.
  • Moors & Cabot bought 35 CME Group shares in Q2 2026, an estimated $9.68K.
  • CME Group made up 0.22% of Moors & Cabot's portfolio in Q2 2026, its #92 holding.
  • Moors & Cabot first reported a position in CME Group in Q3 2019 and has held it in 28 quarters since.
  • Moors & Cabot's CME Group position peaked at $7.69M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.